Release Date: 26/08/09 09:02 Summary: Presentation Briefing Slides Price Sensitive: No Download Document 270.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%